Free. Unsubscribe any time.
Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences, Inc. filed 20 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 35 transactions and 515,016 shares. 2 carry the SEC's AFF10B5ONE flag; 18 name a plan only in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-24, came 42 days after the one before it (2026-07-13) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 2,827 shares, 65,742 fewer than the 68,569 in the filing before it.
- Its 20 plan statements rank 288th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 20 filings on file run from 2025-01-03 to 2026-08-24, and state 5 plan adoption dates, from 2023-03-07 to 2026-02-27.
Trades in Arcus Biosciences, Inc. 35
- Goeltz II Robert C. — 2024-12-31 · S · 3,594 shares
- Azoy Alexander — 2025-09-05 · S · 1,579 shares
- Azoy Alexander — 2025-09-29 · S · 2,831 shares
- Jarrett Jennifer — 2025-10-06 · S · 12,500 shares
- Jarrett Jennifer — 2025-10-08 · S · 37,792 shares
- Goeltz II Robert C. — 2025-10-28 · S · 5,000 shares
- Jaen Juan C. — 2025-10-28 · S · 19,019 shares
- Jaen Juan C. — 2025-10-29 · S · 47,675 shares
- Jaen Juan C. — 2025-10-29 · S · 29,365 shares
- Jaen Juan C. — 2025-10-29 · S · 800 shares
- Jaen Juan C. — 2025-10-30 · S · 4,314 shares
- Jarrett Jennifer — 2025-11-07 · S · 50,291 shares
Adoption dates in Arcus Biosciences, Inc. 5
- 2023-03-07 — stated in 2 filings
- 2024-08-12 — stated in 2 filings
- 2025-06-06 — stated in 3 filings
- 2025-08-08 — stated in 3 filings
- 2026-02-27 — stated in 1 filing
Results prints in Arcus Biosciences, Inc. 8
- 2025-02-18
- 2025-02-25
- 2025-05-06
- 2025-08-06
- 2025-10-28
- 2026-02-25
- 2026-05-05
- 2026-08-05
Trades before a print in Arcus Biosciences, Inc. 2
- 0 days before the 2025-10-28 print — 2025-10-28 · S · Goeltz II Robert C. · 5,000 shares
- 0 days before the 2025-10-28 print — 2025-10-28 · S · Jaen Juan C. · 19,019 shares
- 20 days before the 2025-10-28 print — 2025-10-08 · S · Jarrett Jennifer · 37,792 shares
- 22 days before the 2025-10-28 print — 2025-10-06 · S · Jarrett Jennifer · 12,500 shares
- 26 days before the 2026-08-05 print — 2026-07-10 · S · Jaen Juan C. · 19,799 shares
- 26 days before the 2026-08-05 print — 2026-07-10 · S · Jaen Juan C. · 268 shares
- 27 days before the 2026-08-05 print — 2026-07-09 · S · Jaen Juan C. · 48,502 shares
- 29 days before the 2025-10-28 print — 2025-09-29 · S · Azoy Alexander · 2,831 shares
- 42 days before the 2026-08-05 print — 2026-06-24 · S · Jaen Juan C. · 6,431 shares
- 43 days before the 2026-08-05 print — 2026-06-23 · S · Jaen Juan C. · 14,067 shares
- 43 days before the 2026-08-05 print — 2026-06-23 · S · Jaen Juan C. · 1,697 shares
- 44 days before the 2026-08-05 print — 2026-06-22 · S · Jaen Juan C. · 9,236 shares
Interval to Arcus Biosciences, Inc.’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 2within 10 days
- 0shortest, days
- 1no later print
- Goeltz II Robert C. 2025-10-28 · S · 0 days before the 2025-10-28 print · Chief Financial Officer
- Jaen Juan C. 2025-10-28 · S · 0 days before the 2025-10-28 print · President
Adoption dates Arcus Biosciences, Inc. states
- 2023-03-07 in 2 filings
- 2024-08-12 in 2 filings
- 2025-06-06 in 3 filings
- 2025-08-08 in 3 filings
- 2026-02-27 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person on August 12, 2024”
Reported results dates on file
- 2025-02-18
- 2025-02-25
- 2025-05-06
- 2025-08-06
- 2025-10-28
- 2026-02-25
- 2026-05-05
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.